ERYTHEMATOTELANGIECTATIC ROSACEA

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting ERYTHEMATOTELANGIECTATIC ROSACEA:

# Drug Count
0 METHOTREXATE SODIUM 16
1 METHOTREXATE 14
2 LEFLUNOMIDE 9
3 SECUKINUMAB 9
4 HYDROXYCHLOROQUINE SULFATE 8
5 OMALIZUMAB 8
6 FOLIC ACID 7
7 DICLOFENAC SODIUM 5
8 AMLODIPINE 4
9 AMLODIPINE BESYLATE 2
See all common drugs associated with ERYTHEMATOTELANGIECTATIC ROSACEA

ERYTHEMATOTELANGIECTATIC ROSACEA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM HYALURONATE 1 0.0012
1 GLYCERIN SUPPOSITORY 1 0.0004
2 GLYCERIN SUPPOSITORIES 1 0.0004
3 INFLIXIMAB-DYYB 1 0.0003
4 CARBOXYMETHYLCELLULOSE SODIUM 1 0.0002
5 ACETAZOLAMIDE SODIUM 1 0.0002
6 BETAMETHASONE DIPROPIONATE 1 0.0001
7 OMALIZUMAB 8 0.0001
8 HYDROXYCHLOROQUINE SULFATE 8 0.0001
9 LEFLUNOMIDE 9 0.0001
See all drugs enriched for association with ERYTHEMATOTELANGIECTATIC ROSACEA